Navigation Links
Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
Date:2/10/2009

>

"AR9281 operates within the third branch of the arachidonic acid pathway and represents a potentially more specific and selective approach to intervene in metabolic and inflammatory diseases. The first two branches of this critical regulatory pathway have been targeted by several commercially successful marketed anti-inflammatory drugs including Aspirin(R) (acetylsalicylic acid), Motrin(R) (ibuprofen), Singulair(R) (Montelukast) and Celebrex(R) (celecoxib). We designed our Phase IIa trial to further validate the role of s-EH in the pathophysiology of disease and to lay the groundwork for further exploration of s-EH inhibition in treating a broad range of serious diseases including type 2 diabetes, hypertension and inflammatory disorders," commented Randall Whitcomb, M.D., Chief Medical Officer of Arete.

The results of a Phase I clinical program consisting of two double-blind, placebo-controlled studies demonstrated that AR9281 was safe and well tolerated in healthy volunteers. The studies met all safety, tolerability, pharmacokinetic and pharmacodynamic endpoints. In addition, AR9281 has shown favorable results in various published and proprietary in vitro and in vivo assays for potency, selectivity, efficacy, ADME, toxicity and safety.

About Arete Therapeutics Inc.

Arete Therapeutics is a privately-held biotechnology company dedicated to the discovery and development of novel drugs to treat type 2 diabetes, hypertension and inflammatory disorders. It is the world's leading company focused on s-EH, an important enzyme for the metabolism of arachidonic acid that plays an essential role in metabolic, inflammatory and cardiovascular physiology. The Company was founded by Dr. Bruce Hammock, a Professor at the University of California, Davis, who discovered s-EH. The Company has raised a total of over $51 million in Series A financing led by Frazier Healthcare Ventures, Alta Part
'/>"/>

SOURCE Arete Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
2. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
3. Arete Therapeutics Appoints Donald Santel to Board of Directors
4. CareTech Solutions Service Desk Equals Help Desk Plus
5. Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community
6. CareTech Solutions Named Best in KLAS for Extensive IT Outsourcing Services
7. EnovateIT Partners with CareTech Solutions to Create a Custom Product for Crittenton Hospital Medical Center, One of the Nation's Most Wired Hospitals
8. Prime Therapeutics Receives TIPPS Certification
9. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
10. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
11. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... , ... " Selfie on a Stick ” was featured on NewsWatch as ... available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted ... memories. , Almost every smartphone has an incredibly powerful camera built into it. And ...
(Date:7/3/2015)... Red Deer, Alberta (PRWEB) , ... July 03, 2015 , ... ... Camp host their 24-Hour Train-a-Thon where they provide members of the Red Deer community ... This year’s full day of fitness training, games, food, events and entertainment raised thousands ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Mississippi. The premium frozen yogurt chain was listed as #22 on the Inc. 500 ... Avenue, New Albany, MS 38652, will have a grand opening event on July 4, ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, ... The opening is now the 19th sweetFrog store located in the Lone Star State. ... of fastest growing companies in 2014. , The store, which opened July 1 at ...
(Date:7/2/2015)... Alexandria, VA (PRWEB) , ... July 02, 2015 ... ... applauds Congresswoman Donna Edwards (D-Md.) for her introduction of the Stop Overdose Stat ... bill introduced by Senator Jack Reed (D-R.I.), this Act seeks to decrease drug ...
Breaking Medicine News(10 mins):Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3
... ... cosmetic surgeons in Dallas and a “Best Physician in America,” Benjamin ... of facial rejuvenation in the Facial Plastic Surgery Clinics of North ... innovative approach combines surgery and long-term facial filler treatments to achieve ...
... University study involving 2,453 women ages 18 to 68 found ... partner contributed to higher ratings of pleasurable and satisfying sex. ... to improve the comfort of sexual intercourse and to reduce ... is available on women,s use of lubricants or associated vaginal ...
... of Health Care Reform Bill , Critical legislation ... HARRISBURG, Penn., Nov. 8 , SUMMARY: ... health care reform legislation that would strengthen Medicare for seniors ... Americans out of affordable health coverage. , The ...
... and Democratic leaders held a press conference following the House passage ... The bill passed by a vote of 220 to 215. ... of my colleagues just received a call from the President of ... for the American people. I thank the President for his tremendous ...
... ... about their health risks, especially those linked to exposure to chemicals, atomic agents and ... is two times more prevalent in veterans, especially those who once smoked or currently ... ...
... hailed passage of the Affordable Health Care for America ... consumers, hold insurance companies accountable and increase access to ... option. , "Teddy Roosevelt, FDR and Harry Truman would ... vote ranks among our country,s proudest achievements. Today we ...
Cached Medicine News:Health News:Dallas Facial Plastic Surgeon Publishes Cutting-Edge Novel Approach To Facelift Technique 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3
(Date:7/2/2015)... BURLINGTON, Mass. , July 2, 2015 /PRNewswire/ ... U.S. and European retinal specialists identify less frequent ... macular edema (DME), due to the burden on ... semi-monthly anti-vascular endothelial growth factor (VEGF) injections, which ... compound, Allergan/Molecular Partners, abicipar pegol, which is in ...
(Date:7/2/2015)... July 2, 2015  Konica Minolta, Inc. (Konica Minolta) ... it has acquired Sawae Technologica Ltda., an X-ray system ... , through its Brazilian healthcare sales company, Konica ... Local Brazil market investment ... population exceeding 200 million, significant healthcare technical advancements and ...
(Date:7/2/2015)... Ill. , July 2, 2015  AbbVie (NYSE: ... results on Friday, July 24, 2015, before the market ... of the earnings conference call at 8 a.m. Central ... AbbVie,s Investor Relations website at www.abbvieinvestor.com . An ... 11 a.m. Central time. About AbbVie ...
Breaking Medicine Technology:Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... Aethlon Medical, Inc. (OTC Bulletin Board: ... devices to address infectious disease and cancer, disclosed ... the Aethlon Hemopurifier® within U.S. Government programs that ... against bioterror threats. The Aethlon Hemopurifier® is the ...
... Sept. 21 Amedica Corporation (AC), a spinal ... unique silicon nitride (SiN) ceramic technologies, announced today ... held, well-known medical device company focused on the ...  Development efforts at Boca Raton-based US Spine have ...
Cached Medicine Technology:Aethlon Medical Reestablishes Biodefense Programs 2Aethlon Medical Reestablishes Biodefense Programs 3Aethlon Medical Reestablishes Biodefense Programs 4Aethlon Medical Reestablishes Biodefense Programs 5Aethlon Medical Reestablishes Biodefense Programs 6Amedica® Corporation Acquires US Spine, Further Securing Its Leadership Position in the Spinal Device Marketplace 2Amedica® Corporation Acquires US Spine, Further Securing Its Leadership Position in the Spinal Device Marketplace 3
Inquire...
Inquire...
Hydragel K20 is Sebia's quality line of manual agarose gel electrophoresis products. Samples are applied utilizing the same patented applicator combs that is used for sample application on the HYDRAS...
... a new device for skin extension.Thanks to ... strips, it allows a constant and powerful ... other devices capacities. Such effectiveness makes the ... it is removed before 30 days. Furthermore ...
Medicine Products: